International Clinical Trial: Prediction of Cancer-Associated Thrombosis by Integrating Novel Four Coagulation Parameters and Plasma Proteomics: A Prospective Cohort Study

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134872) titled 'Prediction of Cancer-Associated Thrombosis by Integrating Novel Four Coagulation Parameters and Plasma Proteomics: A Prospective Cohort Study' on Oct. 21.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Condition: Cancer-associated venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE)

Intervention: Model Development Cohort:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-11-01

Target Sample Size: Model Development Cohort:1400;Temporal Validation Coh...